These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 1082397)
1. The value of tests for antibodies to DNA in monitoring the clinical course of SLE. A long-term study using the Farr test and the DNA counterimmunoelectrophoretic method. Edmonds JP; Johnson GD; Ansell BM; Holborow EJ Clin Exp Immunol; 1975 Oct; 22(1):9-15. PubMed ID: 1082397 [TBL] [Abstract][Full Text] [Related]
2. Disease activity in the nephritis of systemic lupus erythematosus in relation to serum complement concentrations. DNA-binding capacity and precipitating anti-DNA antibody. Cameron JS; Lessof MH; Ogg CS; Williams BD; Williams DG Clin Exp Immunol; 1976 Sep; 25(3):418-27. PubMed ID: 1085678 [TBL] [Abstract][Full Text] [Related]
3. Respiratory involvement in systemic lupus erythematosus. A clinical and immunological study. Holgate ST; Glass DN; Haslam P; Maini RN; Turner-Warwick M Clin Exp Immunol; 1976 Jun; 24(3):385-95. PubMed ID: 1084819 [TBL] [Abstract][Full Text] [Related]
4. Correlation between the levels of antinuclear antibodies, anti-DNA antibodies, and complement in systemic lupus erythematosus. Nguyen CP; Cao VV; Fehér J; Gergely P Acta Med Hung; 1988; 45(2):145-59. PubMed ID: 3266790 [TBL] [Abstract][Full Text] [Related]
5. The significance of serial measurements of serum complement C3 and C4 components and DNA binding capacity in patients with lupus nephritis. Garin EH; Donnelly WH; Shulman ST; Fernandez R; Finton C; Williams RL; Richard GA Clin Nephrol; 1979 Oct; 12(4):148-55. PubMed ID: 315852 [TBL] [Abstract][Full Text] [Related]
6. [Capacity to predict a recurrence of lupus erythematosus using double-stranded anti-DNA antibodies and Farr technique]. Massardo L; Martínez ME; Pérez R; Ramírez V; Foradori A; González A; Radrigán F; Gutiérrez F; Jacobelli S Rev Med Chil; 1999 Apr; 127(4):411-20. PubMed ID: 10451606 [TBL] [Abstract][Full Text] [Related]
7. Late onset systemic lupus erythematosus and lupus-like disease in patients with apparent idiopathic glomerulonephritis. Adu D; Williams DG; Taube D; Vilches AR; Turner DR; Cameron JS; Ogg CS Q J Med; 1983; 52(208):471-87. PubMed ID: 6606818 [TBL] [Abstract][Full Text] [Related]
9. Anticardiolipin antibodies: association with anti-DNA antibodies, disease activity, renal involvement and a history of thrombosis in systemic lupus erythematosus. Reul R; Kádár J; Bodó I; Gergely P Acta Med Hung; 1992-1993; 49(3-4):201-5. PubMed ID: 1345458 [TBL] [Abstract][Full Text] [Related]
10. [Systemic lupus erythematosus in children with renal and hematologic manifestations. Relation to anti-nDNA antibodies]. Martínez-Cordero E; Riebeling-Navarro CG; López-Zepeda J; Martínez-Miranda E; Negrete-García MC Bol Med Hosp Infant Mex; 1989 Jan; 46(1):11-21. PubMed ID: 2785391 [TBL] [Abstract][Full Text] [Related]
11. The significance of discrepant Farr and Crithidia luciliae tests. McGuigan L; Edmonds J; Wellings G; Jones M J Rheumatol; 1984 Apr; 11(2):172-4. PubMed ID: 6610050 [TBL] [Abstract][Full Text] [Related]
12. Relationships between antibodies to native DNA and glomerulonephritis in systemic lupus erythematosus. Tron F; Bach JF Clin Exp Immunol; 1977 Jun; 28(3):426-32. PubMed ID: 302165 [TBL] [Abstract][Full Text] [Related]
13. Predictive value of anti-DNA antibody and selected laboratory studies in systemic lupus erythematosus. Ludivico CL; Zweiman B; Myers AR; Hebert J; Green PA J Rheumatol; 1980; 7(6):843-9. PubMed ID: 6970815 [TBL] [Abstract][Full Text] [Related]
14. [Comparison of severity and native anti-DNA antibody levels in systemic lupus erythematosus. Serodiscordant lupus]. Manent-Ducreuzet C; Margulis J; Kahn MF Rev Rhum Mal Osteoartic; 1981 Nov; 48(11):705-12. PubMed ID: 6975965 [TBL] [Abstract][Full Text] [Related]
15. Autoimmunity and laboratory testing for systemic lupus erythematosus (SLE) and allied diseases. Deodhar SD Lab Res Methods Biol Med; 1983; 8():89-100. PubMed ID: 6358749 [TBL] [Abstract][Full Text] [Related]
16. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome. Inanç M; Donohoe S; Ravirajan CT; Radway-Bright EL; Mackie I; Machin S; Isenberg DA Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748 [TBL] [Abstract][Full Text] [Related]